chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ON 03/07/2022 AROUND 3 TO 4PM A PEDIATRIC PFIZER VACCINE WAS ADMINISTERED TO PATIENT NOT DILUTED WITH 1.3ML  0.9% SODIUM CHLORIDE. PATIENT RECEIVED 0.2ML IN THE MUSCLE OF LEFT ARM . ACCORDING TO GUARDIAN ON 03/08/2022 , WHO WAS NOTIFIED OF THE EVENT , STATED PATIENT IS DOING FINE AND WAS JUST SLIGHTLY LETHARGIC ON NIGHT OF 03/07/2022 WITH SOME PAIN AT THE INJECTION SITE
chills; Had chills after receiving third (booster) shot.; This is a spontaneous report from a contactable consumer.  A patient of unspecified age and gender received bnt162b2 (BNT162B2) (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Lot Number: unknown; Expiration Date: Unknown), via an unspecified route of administration on 2021, as dose 3 (booster), single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received BNT162B2 as dose 1 and dose 2 respectively, for COVID-19 immunisation. . On an unspecified date in 2021, the patient experienced chills after receiving third (booster) shot. The outcome of all the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Immediately after vaccines were administered pt had redness, heat, swelling at site of injection as well as some induration. Pt. was observed for 30-45 min for SOB or changes in his skin. Pt finally was released w/ decrease in symptoms. Advised to apply compress (cool) and rtn if worse or seek ER.
1st dose administered to patient from expired vial; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (1st dose administered to patient from expired vial) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Sep-2021 at 8:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (1st dose administered to patient from expired vial). On 01-Sep-2021, EXPIRED PRODUCT ADMINISTERED (1st dose administered to patient from expired vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment medications were not reported. Patient dose not have any adverse reaction   This case was linked to MOD-2021-305415 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Sep-2021: Follow-up document received and updated route of administration and anatomical location On 07-Sep-2021: Follow-up received and contains no significant information.
Severe body aches; Shortness of breath; Chest pains; Brain fog; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 17Apr2021 at 13:45 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included unspecified birth control medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took sulfur (MANUFACTURER UNKNOWN) and experienced drug allergy. On 22Apr2021 at 23:00, the patient experienced severe body aches, shortness of breath, chest pains, brain fog and fatigue. On 23Apr2021, the patient underwent SARS-CoV-2 test (blood test) and the result was negative. The event resulted in emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events severe body aches, shortness of breath, chest pains, brain fog and fatigue was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Received PNEUMOVAX 23 vaccine June 29. Experienced swelling and burning sensation at injection site and upper arm. Did not seek treatment and subsided after 3-4 days.
13JUN94 pt recvd vax & devel high fever worse 14JUN94 t102.7; fine generalized macules all over, large local react; excess irritability & crying & sleeping;
Presented to ED w c/o COVID-like symptoms x 2 days; admitted for COVID-19 infection; no pna; pt suffered acute stroke; pt had syncopal epsisode early morn 1/21; code blue called; unable to be resuscitated and subsequently expired.
Bad fever/ Fever was under 100/ last night temperature was 101.5 and today 103.8/ worse today; Chills; Fatigue; Muscle pain; Severe diarrhea; Abdominal cramping; This is a spontaneous report from a contactable consumer who reported for herself, a female patient of an unspecified age (reported as 48, unspecified units) who received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date unknown), via an unspecified route of administration on 04Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient stated she got the vaccine on 04Jan2021. Patient was experiencing bad fever, chills, fatigue, muscle pain, severe diarrhea and abdominal cramping. Patient did not know if manufacturer could help her with the side effects because her doctor was closed. Patient has experienced all the symptoms since Saturday, 09Jan2021. Fever was under 100 from 09Jan2021 until 15Jan2021 and last night (15Jan2021) temperature was 101.5 and today, 16Jan2021, 103.8. Patient stated worse today. Patient has taken Tylenol. The outcome of bad fever was not recovered, while outcome of the remaining events was unknown.  Information on Lot/Batch number has been requested.
Systemic: Body Aches Generalized-Mild, Systemic: Confusion-Medium, Systemic: Diarrhea-Medium, Systemic: Dizziness/Lightheadedness-Medium, Systemic: Exhaustion/Lethargy-Medium, Systemic: Fever-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Visual Changes/Disturbances-Medium, Systemic: Weakness-Medium
DEATH; FEEL SIDE EFFECTS/SYMPTOMS; This spontaneous report received from a consumer concerned a 49 year old male an unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient was healthy. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown; expiry date: Unknown) dose, start therapy date were not reported 1 total administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date (1 day after receiving vaccine), the patient experienced side effects/symptoms. Four day later, he passed away. It was not reported, if the autopsy was performed or not. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient died of death on an unspecified date, and the outcome of feel side effects/symptoms was not reported. This report was serious (Death). This case is linked to 20210608311 (same reporter).; Sender's Comments: V0 - 20210745184-Covid-19 vaccine ad26.cov2.s-Death. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Throbbing at injection sight.  Hot and cold. Profuse sweating. Racing heartbeat. Nausea. No appetite. Body aches
Day-2 to 7: Could not lift right arm lasted for 1 week. Week 2: Soreness at injection site radiates down arm and up neck.
Her top lip was swollen.; Then she had some kind of allergic reaction; Some time in October, she got rash again.; She started with an itchy rash on whole body some time in June.; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Her top lip was swollen.), RASH PRURITIC (She started with an itchy rash on whole body some time in June.), RASH (Some time in October, she got rash again.) and HYPERSENSITIVITY (Then she had some kind of allergic reaction) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 015M20A) for COVID-19 vaccination.     Concomitant products included METFORMIN, OMEPRAZOLE, LEVOTHYROXINE, VENLAFAXINE, GLIMEPIRIDE, LOSARTAN and ATORVASTATIN for an unknown indication.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In June 2021, the patient experienced RASH PRURITIC (She started with an itchy rash on whole body some time in June.). In October 2021, the patient experienced RASH (Some time in October, she got rash again.). On an unknown date, the patient experienced LIP SWELLING (Her top lip was swollen.) and HYPERSENSITIVITY (Then she had some kind of allergic reaction). The patient was treated with PREDNISONE at an unspecified dose and frequency. At the time of the report, LIP SWELLING (Her top lip was swollen.), RASH (Some time in October, she got rash again.) and HYPERSENSITIVITY (Then she had some kind of allergic reaction) outcome was unknown and RASH PRURITIC (She started with an itchy rash on whole body some time in June.) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   HCP denies to give her booster.
Chills; fever and a temperature (unspecified); Tiredness; Weak; This is a spontaneous report from a contactable consumer. An 84-year-old male patient (reporter's husband) received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EL9262, expiry date unknown), via an unspecified route of administration on 29Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter and the patient got the vaccine and it was reported that the patient got side effects on 30Jan2021. The patient got lot of chills, had fever and a temperature (unspecified). The patient also had tiredness and was very weak. He had to go to the bed in the afternoon and that was 24 hours later. The outcome of the events was unknown.
Swollen and pain on underarm/lymph node on side of vaccine; started day after second dose of vaccine
Patient had seizures. History of seizure disorder, well controlled on Keppra. Gived Tdap vaccine on 1/22/07 and had 2 seizures that night and the next day.
Pt reported  for second dose of Moderna COVID-19 vaccine. Pt stated to vaccination nurse of reaction (shortness of breath, warmth in her lips) following first vaccine Pt denied throat/tongue swelling, and did not require treatment, symptoms/reaction resolved on its own. Pt received second dose vaccine at 3:21 PM and was advised to remain in observation for 30 mins. At 3:30 PM pt reported an onset of "swollen lips and a scratchy throat". This RN assessed pt and noticed slightly swollen and red right upper lip and pt reported her throat felt scratchy.Pt denied any throat or tongue swelling. Pulse ox 97% no difficulty breathing noted. At 3:50 PM pt reported an increase in lip swelling and scratchy throat. 25 mg of Benadryl was administered IM in R deltoid at 3:50 PM. No throat/tongue swelling; no other symptoms of anaphylaxis noted at this time. RN came in at 3:55 PM and took pt vital signs BP: 118/80, O2: 95% Pulse: 82 RR: 20. Pt reported no increase in lip swelling and noted an improvement from throat scratching. At 4:20 PM this RN retook pt vital signs, BP: 120/60, O2: 95%, Pulse: 77, RR: 18. At 4:20 PM pt reported a decrease in lip swelling and a decrease in throat scratching, pt states she is comfortable to go home, husband outside waiting in car and will be with her through the night. Pt advised if symptoms worsen to call EMS. Pt verbalized understanding.
toenails & fingernails turned orange,on a few of her fingernails it looks like blood around the cuticles; her that the capillaries under her nails had burst,on a few of her fingernails it looks like blood around the cuticles; Her toes are worse; This spontaneous case was reported by a consumer and describes the occurrence of NAIL DISCOLOURATION (toenails & fingernails turned orange,on a few of her fingernails it looks like blood around the cuticles), PETECHIAE (her that the capillaries under her nails had burst,on a few of her fingernails it looks like blood around the cuticles) and PAIN IN EXTREMITY (Her toes are worse) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NAIL DISCOLOURATION (toenails & fingernails turned orange,on a few of her fingernails it looks like blood around the cuticles), PETECHIAE (her that the capillaries under her nails had burst,on a few of her fingernails it looks like blood around the cuticles) and PAIN IN EXTREMITY (Her toes are worse). At the time of the report, NAIL DISCOLOURATION (toenails & fingernails turned orange,on a few of her fingernails it looks like blood around the cuticles), PETECHIAE (her that the capillaries under her nails had burst,on a few of her fingernails it looks like blood around the cuticles) and PAIN IN EXTREMITY (Her toes are worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was reported.  No treatment drug was reported.
No additional adverse effects reported.; one patient was administered improperly stored VARIVAX.; This spontaneous report was received from a medical assistant and refers to a 13 month old patient. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  On 13-FEB-2020, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # S019581 with expiration date of 25-JUN-2021, for prophylaxis (strength and route of administration were not reported).  The varicella virus vaccine live (oka/merck) (VARIVAX) was reconstituted with properly stored sterile diluent (STERILE DILUENT MRK) with lo# S021105 with expiration date of 14-MAY-2022.     No adverse effects were reported.  It was stated that the vaccine underwent a temperature excursion of 6 °F (degrees Fahrenheit) to 14°F for 3 hours and 59 minutes; previous temperature excursion was done: 6°F to 14°F for 8 hours and 51 minutes.  The call was because of a "data logger".
Reported:she has had worsening arthralgias all over, and is fully vaxed with spike protein gene therapy and had booster 9/10/21
Awoke 3/20/21 @ 4:30A with nausea and vertigo. Vertigo severe causing vomitting when attempting to get out of bed. By 3/24/21 vertigo greatly less than still present with certain movements (looking down, arising from lying position, turning from side to side in bed) utilized increased fluids and OTC Dramamine
Resident had no po intake or urinary output on 4/21-22/2022. Resident unable to comprehend using a straw or chewing food. Slept for over 24 hours and unable to hold up her head. Resident was transported to hospital at that time where she was diagnosed with Covid, pneumonia and sepsis. Discharge noted septic shock, hyernatremia, dehydration, weakness & metabolic encphalopathy overlying advance dementia. Prior to be sent to hospital on 4/22/2022, resident was having increased confusion and tearfulness. Increased behaviors noted on 4/4/22, with increase in Depakote. Fall on 3/30/22.
Bad rash on lower lip started to appear 2 weeks after they got first Covid booster; This spontaneous case was reported by a patient and describes the occurrence of CHEILITIS (Bad rash on lower lip started to appear 2 weeks after they got first Covid booster) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 068H21A, 004C21A and 021B21A) for COVID-19 prophylaxis.     Concurrent medical conditions included Blood pressure high (takes blood pressure medication). Concomitant products included LISINOPRIL and WOMEN'S MULTI [ASCORBIC ACID;BETACAROTENE;BIOTIN;CALCIUM;CHROMIUM;COLECALCIFEROL;COPPER;ELEUTHEROCOCCUS SENTICOSUS ROOT;FOLIC ACID;IODINE;IRON;MAGNESIUM;MANGANESE;NICOTINIC ACID;PANTOTHENIC ACID;POTASSIUM;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;SELENIUM; for an unknown indication.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHEILITIS (Bad rash on lower lip started to appear 2 weeks after they got first Covid booster). The patient was treated with CORTISONE at a dose of cortisone 10 over the counter; HYDROCORTISONE at a dose of Hydrocortisone 1.5; HYDROCORTISONE at a dose of Hydrocortisone 2.5 and TACROLIMUS at a dose of 0.1 % percent. At the time of the report, CHEILITIS (Bad rash on lower lip started to appear 2 weeks after they got first Covid booster) had not resolved.            Concomitant medication also included only blood pressure medication and Hydra something. Treatment medication included patient had been to the dermatologist and MDs and had tried all types of creams and ointments. Patient had Cortisone 10 Over the counter and Keto something.   This case was linked to MOD-2022-633016 (Patient Link).
Noticed reaction when leaving office visit after vaccines. Coughing, drooling saliva, rapid breathing were symptoms noticed by mother when they arrived home. As per mother nothing esle was ingested.
This case was reported by a nurse and described the occurrence of allergic reaction in an adult female subject of unspecified age who was vaccinated with ENGERIX B. On an Unspecified date the subject received 1st dose of ENGERIX B. An unspecified amount of time after administration of ENEGERIX B, the subject developed malaise and frequent diarrhea with cramping. On unspecified date, the subject later received 2nd dose, the subject developed a fever to 102 f that lasted for 3 months. The reporter referred to these symptoms as an allergic reaction. The outcome of the events was not reported.
8 days after receiving my first COVID booster, I developed severe systemic urticaria. Mildly responsive to Benadryl. Currently ongoing for 60 hours.
This spontaneous report was received from a consumer (who was enrolled in the market research program) regarding a female patient of unknown age. Information regarding concomitant therapies, concurrent conditions and medical history was not reported. On an unknown date, the patient was vaccinated with GARDASIL (strength, dose, route, lot # and expiration date unknown) for prevention of human papillomavirus. It was reported that, the consumer watched a program on 20/20, where a family believed that, their daughter experienced serious side effects from GARDASIL. The outcome of the event was unknown. The reporter considered the event to be related to suspect therapy. The reporter considered the event to be serious (medically significant).
Patient received dose after refrigerated expiry date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received dose after refrigerated expiry date) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received dose after refrigerated expiry date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received dose after refrigerated expiry date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information was unknown. Action taken with mRNA-1273 in response to the events was not applicable.
Soar arm where the shot was given; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 52-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th November 2019, the patient received Shingrix. In November 2019, less than a day after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient was going to get side effects from the 1st shot or 2nd and asked how long would it be. The patient received Shingrix and had sore arm where the shot was given but not much else yet. The patient was not comfortable giving the rest information.
Fever, aches, chills, late period, light spotting during a late minstrel cycle.
Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Abdominal Pain-Medium, Systemic: Blood Disorder  (diagnosed by MD)-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Joint Pain-Medium, Additional Details: patient experienced a swelling lump the day after the vaccine   told patient to take benadryl and to follow up with the pharmacy or dr if the symptoms continue to worsen  she called on the 18th and said the arm had a large swollen lump and she experienced weakness of the abdomen and was having trouble bending and urinating and has to leave work  she did have a similiar reaction to the last vaccine but this is much worse  advised going to urgent care or the er for follow up
When I woke up, I realized I was mumbling or not coming across clearly. I couldn't taste on the right side of my mouth. When I went to brush my teeth, the toothpaste and water wouldn't stay in my mouth. I looked in the mirror and noticed that right side of my face was not moving at all. I called my doctor, but nobody answered. My older brother came to my house and he looked at my face. He thought it may have just been swelling. On Monday, I went to urgent care. The doctor I saw used to work on a stroke unit in a hospital. She diagnosed me with Bell's Palsy and gave me prednisone. I saw my PCP, three days after I started the prednisone. She told me that there wasn't much she could do and I would have to wait it out. She said it could take 2 weeks to 6 months to clear up. Two weeks after my appointment, I saw my doctor again and she gave me medicine to help me sleep at night. Slowly, it started to get better. The beginning of August is when I felt that I was closer to being fully recovered. If looking for it, you can still notice that my smile isn't full and when I try to close my eyes, my eye remains slightly open. Overall, I feel much better.